Target intelligence / Profile preview

Immunoglobulin lambda variable 1-41 (pseudogene) (IGLV1-41)

Target
IGLV1-41
Molecular classification
Other, Immunoglobulin variable gene, Pseudogene
01

Overview

Immunoglobulin lambda variable 1-41 (IGLV1-41) is a member of the immunoglobulin lambda variable region family and is classified as a pseudogene in humans[1][2]. Immunoglobulin lambda variable genes encode the variable region of the lambda light chain in antibodies; however, as a pseudogene, IGLV1-41 does not produce a functional protein product and does not directly participate in antibody structure or function. In the human genome, these genes are found within the immunoglobulin lambda locus on chromosome 22, and the region displays extensive genetic diversity and segmental duplications[3][4]. Pseudogenes such as IGLV1-41 arise from gene duplication events followed by mutations that disrupt normal gene function. IGLV1-41 is not a therapeutic target, nor is it involved in disease mechanisms or drug interactions. It may be referenced only in immunogenetic annotation or genomic analysis of the immunoglobulin lambda locus[2][3][4].

Other names
IGLV141V1-14PIGLV1-41

Beyond the preview

Go deeper on Immunoglobulin lambda variable 1-41 (pseudogene) (IGLV1-41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 1-41 (pseudogene) (IGLV1-41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call